XT
PCSA icon

XTX Topco’s Processa Pharmaceuticals PCSA Stock Holding History

XTX Topco’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5K Buy
+13,292
New +$34.4K ﹤0.01% 3865

Other funds holding PCSA

CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

XTX Topco's PCSA Position: Q2 2026 in Review

XTX Topco opened a new position in Processa Pharmaceuticals (PCSA) in Q2 2026: 13,292 shares worth $25.5K. The stake represents ﹤0.01% of the portfolio and ranks #3865 among its holdings.

11 funds tracked by Wall St. Rank hold PCSA as of Q2 2026.

  • XTX Topco held 13,292 shares of Processa Pharmaceuticals worth $25.5K as of Q2 2026.
  • Processa Pharmaceuticals was a new XTX Topco position in Q2 2026.
  • Processa Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3865 holding.
  • 11 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.